Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673191 · ClinicalTrials.gov registry record · Phase 2
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
A Phase 2 study, sponsored by Retinal Consultants of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01673191 is a Phase 2 study that has completed, run by Retinal Consultants of Arizona. The registered enrollment target is 40 participants.
The verdict
NCT01673191, a Phase 2 study, has completed, sponsored by Retinal Consultants of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.
Interventions
- DRUG Dexamethasone intravitreal implant
- DRUG Steroid plus NSAID eye drop combination therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673191
The ClinicalTrials.gov registry entry for NCT01673191 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Retinal Consultants of Arizona, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone intravitreal implant is the first listed.
NCT01673191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01673191 about?
NCT01673191 is a clinical study titled "A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus". There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.
What is the current status of trial NCT01673191?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2012-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01673191?
The interventions under investigation include: Dexamethasone intravitreal implant (DRUG), Steroid plus NSAID eye drop combination therapy (DRUG).
Who is sponsoring clinical trial NCT01673191?
This trial is sponsored by Retinal Consultants of Arizona, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.